Get started
Author

Sandra J. Sivananthan

Observed names: Sandra J Sivananthan, Sandra Sivananthan, Sivananthan, Sandra J.
ORCID: 0009-0008-1707-7326
Observed ORCID: 0009-0008-1707-7326
OpenAlex ID: A5033781462
Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
2013 · Mark T. Orr, Christopher B. Fox, et al. · Journal of Controlled Release · 106
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
2014 · Christopher B Fox, Sandra J Sivananthan, et al. · Journal of Nanobiotechnology · 82
PDF
Particle Sizing of Nanoparticle Adjuvant Formulations by Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA)
2016 · Michelle Y. Chan, Quinton M. Dowling, et al. · Methods in molecular biology · 74
Control of Heterologous Simian Immunodeficiency Virus SIV smE660 Infection by DNA and Protein Coimmunization Regimens Combined with Different Toll-Like-Receptor-4-Based Adjuvants in Macaques
2018 · Shakti Singh, Eric G. Ramírez-Salazar, et al. · Journal of Virology · 36
PDF
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions
2023 · Karl J. Fisher, Robert Kinsey, et al. · npj Vaccines · 28
PDF
Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions
2010 · Christopher B. Fox, Susan Lin, et al. · Pharmaceutical Development and Technology · 28
Optimizing a Multi-Component Intranasal Entamoeba Histolytica Vaccine Formulation Using a Design of Experiments Strategy
2021 · Mayuresh M. Abhyankar, Mark T. Orr, et al. · Frontiers in Immunology · 24
PDF
Charged aerosol detection to characterize components of dispersed-phase formulations
2013 · Christopher B. Fox, Sandra J. Sivananthan, et al. · Advances in Colloid and Interface Science · 15
Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3 M−052 liposomes): In vitro characterization
2022 · Brynn M. Murphy, John Z. Chen, et al. · International Journal of Pharmaceutics · 13
PDF
Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity
2013 · HW Millie Fung, Traci JT Mikasa, et al. · Journal of Nanobiotechnology · 11
PDF
Staining and Transfer Techniques for SDS-PAGE Gels to Minimize Oil-in-Water Emulsion Adjuvant Interference
2016 · Alicia M. Schwartz, Michelle Y. Chan, et al. · Methods in molecular biology · 8
Modulating Potency: Physicochemical Characteristics are a Determining Factor of TLR4-Agonist Nanosuspension Activity
2014 · Quinton M. Dowling, Sandra J. Sivananthan, et al. · Journal of Pharmaceutical Sciences · 7
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques
2024 · Mayuresh M. Abhyankar, Feifan Xu, et al. · Human Vaccines & Immunotherapeutics · 4
Screening of Oligomeric (Meth)acrylate Vaccine Adjuvants Synthesized via Catalytic Chain Transfer Polymerization
2023 · Cordula S. Hege, Amy Stimpson, et al. · Polymers · 1
PDF
Works count: 15
Citation count: 437
H-index: 10
I10-index: 10
Year
Topic
Type